U. Washington's Targeted Gene Panel Pinpoints Breast Cancer Mutations in Quarter of Patients with Negative BRACAnalysis Test Results | GenomeWeb

BOSTON (GenomeWeb News) – A targeted gene panel developed by University of Washington researchers found that some women, who had a family history of breast and ovarian cancer, and who had received negative test results from Myriad Genetics' BRACAnalysis test, in fact, had BRCA1 and BRCA2 mutations that BRACAnalysis did not pick up.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.